Skip to Main Content

Paper Details

Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice.
bioRxiv
22
2020
COVID, COVID-19, E6 cells, RDV, RNA-dependent RNA polymerase, Remdesivir, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 RNA polymerase, Severe acute respiratory syndrome coronavirus, Vero, Vero E6 cells, adenosine, human, human airway epithelial cultures, human lung cells, mice, monophosphoramidate, pandemic viral disease, remdesivir

Datasets

Release 1.2